From 2020 and onwards, the Board of Directors will consider an annual dividend of up to 50 per cent of net profit. The proposed dividend will take into account Medicover’s long-term development opportunities and its financial position.
Class A and class B shares are entitled to dividends, but class C shares are not entitled.